Celestica Inc. diskutieren
Celestica Inc.
WKN: 914782 / Symbol: CLS / Name: Celestica / Aktie / Halbleiter / Small Cap /
41,07 €
1,68 %
Celestica Inc. (NYSE: CLS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) was upgraded by analysts at TD Securities from a "hold" rating to a "buy" rating.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $23.00 price target on the stock, up previously from $14.50.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $22.00 price target on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at TD Securities from $23.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at CIBC from $25.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at BMO Capital Markets from $22.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $24.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at Royal Bank of Canada from $30.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at BMO Capital Markets from $27.00 to $32.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at TD Securities from $29.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $29.00 to $32.50. They now have a "buy" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at Royal Bank of Canada from $33.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at BMO Capital Markets from $32.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at TD Securities from $33.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $32.50 to $38.00. They now have a "buy" rating on the stock.
Ratings data for CLS provided by MarketBeat
Celestica Inc. (NYSE: CLS) had its price target raised by analysts at CIBC from $33.00 to $41.00. They now have an "outperform" rating on the stock.
Ratings data for CLS provided by MarketBeat
Neueste Beiträge
StockNews_com in Concord Medical Serv. ADR diskutieren